Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

Pro: Leo planned to start B-ABSSSI Phase 3 trials seven years ago.

http://www.ipharminc.com/press-release/2016/11/16/cellceutix-to-start-brilacidin-phase-3-program-in-absssi

Con: Phase 3 trial = 0

Pro: Leo planned to start B-OM Phase 3 trials three years ago.

http://www.ipharminc.com/press-release/2018/12/17/innovation-pharmaceuticals-completes-end-of-phase-2-meeting-with-fda-brilacidin-oral-rinse-to-advance-into-phase-3-clinical-trials-for-prevention-of-severe-oral-mucositis

Con: Phase 3 trial = 0

Pro: Leo was "laser-focused" on partnerships five years ago.

http://www.ipharminc.com/press-release/2016/12/22/cellceutix-wishes-shareholders-happy-holidays-prepares-for-2017-focused-on-partnerships

Con: Partnership (a real one with non-dilutive funding) = 0

Pro: Leo failed to find a partner so he hired Locust Walk not once but twice.

http://www.ipharminc.com/press-release/2019/9/30/innovation-pharmaceuticals-engages-locust-walk-a-global-life-sciences-transaction-firm

http://www.ipharminc.com/press-release/2020/1/29/innovation-pharmaceuticals-further-engages-locust-walk-to-lead-out-licensing-negotiations-for-rights-to-phase-3-ready-oral-mucositis-drug-candidate

Con: Partnership for B-OM = 0